Crescita Therapeutics Statistics
Total Valuation
CRRTF has a market cap or net worth of 6.64 million. The enterprise value is 885,794.
| Market Cap | 6.64M |
| Enterprise Value | 885,794 |
Important Dates
The next estimated earnings date is Wednesday, March 18, 2026.
| Earnings Date | Mar 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 18.61M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.70% |
| Shares Change (QoQ) | -0.99% |
| Owned by Insiders (%) | 13.48% |
| Owned by Institutions (%) | n/a |
| Float | 16.11M |
Valuation Ratios
The trailing PE ratio is 20.25.
| PE Ratio | 20.25 |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | 14.85 |
| P/OCF Ratio | 4.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.01, with an EV/FCF ratio of 1.98.
| EV / Earnings | 2.70 |
| EV / Sales | 0.05 |
| EV / EBITDA | 2.01 |
| EV / EBIT | n/a |
| EV / FCF | 1.98 |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.12 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.72 |
| Debt / FCF | 0.78 |
| Interest Coverage | -15.96 |
Financial Efficiency
Return on equity (ROE) is 2.83% and return on invested capital (ROIC) is -9.50%.
| Return on Equity (ROE) | 2.83% |
| Return on Assets (ROA) | -2.21% |
| Return on Invested Capital (ROIC) | -9.50% |
| Return on Capital Employed (ROCE) | -4.79% |
| Weighted Average Cost of Capital (WACC) | 6.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.00 |
| Inventory Turnover | 1.85 |
Taxes
| Income Tax | -10,051 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.41% in the last 52 weeks. The beta is 0.31, so CRRTF's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -6.41% |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 0.52 |
| Relative Strength Index (RSI) | 51.80 |
| Average Volume (20 Days) | 6,105 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CRRTF had revenue of 15.84 million and earned 328,095 in profits. Earnings per share was 0.01.
| Revenue | 15.84M |
| Gross Profit | 8.20M |
| Operating Income | -561,423 |
| Pretax Income | 318,044 |
| Net Income | 328,095 |
| EBITDA | 178,765 |
| EBIT | -561,423 |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 5.96 million in cash and 347,479 in debt, with a net cash position of 5.62 million.
| Cash & Cash Equivalents | 5.96M |
| Total Debt | 347,479 |
| Net Cash | 5.62M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 11.67M |
| Book Value Per Share | 0.63 |
| Working Capital | 7.80M |
Cash Flow
In the last 12 months, operating cash flow was 1.46 million and capital expenditures -1.01 million, giving a free cash flow of 447,271.
| Operating Cash Flow | 1.46M |
| Capital Expenditures | -1.01M |
| Free Cash Flow | 447,271 |
| FCF Per Share | n/a |
Margins
Gross margin is 51.77%, with operating and profit margins of -3.54% and 2.07%.
| Gross Margin | 51.77% |
| Operating Margin | -3.54% |
| Pretax Margin | 2.01% |
| Profit Margin | 2.07% |
| EBITDA Margin | 1.13% |
| EBIT Margin | -3.54% |
| FCF Margin | 2.82% |
Dividends & Yields
CRRTF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.70% |
| Shareholder Yield | 2.70% |
| Earnings Yield | 4.94% |
| FCF Yield | 6.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRRTF has an Altman Z-Score of -0.21 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.21 |
| Piotroski F-Score | 5 |